Kiniksa Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Kiniksa Pharmaceuticals (KNSA) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Kiniksa Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Kiniksa Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kiniksa Pharmaceuticals by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $186k | 11k | 17.54 |
| 2023-09-30 | $184k | 11k | 17.37 |
| 2023-06-30 | $114k | 11k | 10.76 |
| 2023-03-31 | $114k | 11k | 10.76 |
| 2022-12-31 | $450k | 30k | 14.98 |
| 2022-09-30 | $385k | 30k | 12.84 |
| 2022-06-30 | $344k | 36k | 9.69 |
| 2022-03-31 | $353k | 36k | 9.94 |
| 2021-12-31 | $418k | 36k | 11.77 |
| 2021-09-30 | $404k | 36k | 11.39 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas